DOJ OKs Supply Chain 'Control Tower' Collaboration Against COVID-19 Drug Shortages
Executive Summary
AmerisourceBergen, McKesson, Cardinal and others can help FEMA deliver hydroxychloroquine and manage critical-drugs supply chain without running afoul of federal antitrust law.
You may also be interested in...
Supply Chain Conversations Should Continue, But Industry Wants More Government Transparency
Healthcare Distribution Alliance CEO Chip Davis says drug wholesalers and suppliers need the government’s information on product demand, just as the government needs industry inventory data, to anticipate and avert shortages.
Global Supply Chain Scrutiny And Investment In Domestic Alternatives For US Drug Shortages
Pharmaceutical supply chains may grow less efficient and less risk prone as US government gets more involved to ensure availability of pandemic and essential medicines. But what about pediatric oncology medicines and other treatments that save lives even though they may not be considered essential?
As Other US Agencies Respond To The Pandemic, FEMA Fine-Tunes Plan Of Action
Industry wonders how emergency agency's COVID-19 public-private partnerships will fit in with the others.